ORINY (ORINY) Stock Price & Analysis
ORINY (ORINY) rose 6.96% to USD 40.63 as of June 9, 2026 at 23:49 UTC, according to Nexqual real-time market data.
ORINY last closed at USD 37.99; the session ranged USD 40.63–40.63 on volume of 1 shares. Market capitalization is $11.45B, with a 52-week range of USD 30.89–42.75 (PNK). Source: Nexqual, June 9, 2026 at 23:49 UTC.
Key Statistics (as of June 9, 2026 at 23:49 UTC)
| Price | USD 40.63 |
|---|---|
| Change | ▲ 6.96% (up) |
| Previous Close | USD 37.99 |
| Open | USD 40.63 |
| Day Range | USD 40.63 – 40.63 |
| 52-Week Range | USD 30.89 – 42.75 |
| Volume | 1 shares |
| Market Cap | $11.45B |
| Exchange | PNK |
Technical Analysis (ORINY)
Nexqual's technical model rates ORINY "STRONG SELL" based on 1 bullish and 6 bearish signals across 124 daily candles, as of June 9, 2026 at 23:49 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Above (USD 37.99) |
| MACD | -0.04 (negative) |
Analyst Ratings (ORINY)
Wall Street analysts rate ORINY "None", per Nexqual as of June 9, 2026 at 23:49 UTC.
| Consensus Rating | None |
|---|
Earnings (ORINY)
| Revenue Estimate | $507.14M |
|---|
Source: Nexqual, June 9, 2026 at 23:49 UTC.
Financials & Fundamentals (ORINY)
| Total Revenue | $1.95B |
|---|---|
| Revenue Growth (YoY) | +17.80% |
| Gross Margin | +64.80% |
| Operating Margin | +27.46% |
| Profit Margin | +27.11% |
| ROE | +48.37% |
| Debt / Equity | 29.43 |
| Current Ratio | 1.77 |
| Total Cash | $199.30M |
| Total Debt | $330.30M |
| Free Cash Flow | $328.26M |
Source: Nexqual, June 9, 2026 at 23:49 UTC.
Financial Health Score (ORINY)
Nexqual rates ORINY's overall financial health "Strong" across five dimensions, as of June 9, 2026 at 23:49 UTC.
| Growth | Strong — Revenue +23% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 65%, operating 27% |
| Balance Sheet | Strong — $199M cash vs $330M debt |
| Cash Flow | Strong — FCF $328M, 17% margin |
| Efficiency | Strong — ROE 48%, ROA 22.1% |
Ownership (ORINY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 218.68M |
| Float | 246.23M |
Source: Nexqual, June 9, 2026 at 23:49 UTC.
Leadership (ORINY)
ORINY is led by Liisa Hurme (age 58), President, CEO & Chairman of Executive Management Board, per Nexqual as of June 9, 2026 at 23:49 UTC.
| President, CEO & Chairman of Executive Management Board | Liisa Hurme (age 58) |
|---|---|
| CFO & Member of Group Executive Management Board | Rene Lindell M.Sc. (age 49) |
| Executive Vice President of Innovative Medicines & Member of Management Board | Berkeley Vincent (age 48) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IPSEY | Ipsen S.A. | USD 42.27 | ▼ 6.15% |
| UCBJY | UCB S.A. | USD 151.74 | ▲ 1.47% |
| RANJY | Randstad NV | USD 15.35 | ▼ 1.67% |
| OUKPY | Metso OYJ | USD 8.86 | ▼ 1.83% |
| CHGCY | Chugai Pharmaceutical Co., Ltd. | USD 22.85 | ▼ 0.91% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 23:49 UTC. This page is informational and not investment advice.